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Phalioidin, which stabilizes F-a&n, has no effect on insulin secretion from intact islets, but penetrates and 
increases gene&n from ialeta previously made permeable using a high voltage discharge technique. Use 
of this highly specifk drug strorugSy suggesti a role for microtilaments composed of F-a&in in the insulin 
secretory process. 
PklllQWl Microjihment Insulin secretion 
1. INTRODUCTION 
The postulated role of the microtubule- 
microfilamentous system in the mechanism of in- 
sulin secretion (11 rests in part on the effects of 
drugs which interfere with mi~otubnle and 
micrrofilament function. Thus col&icine [l], 
vinbW.iue, deutariuxu oxide [2,3], tamI or 
n&axole [4] aa affect ndcrotubule polymeriza- 
tion and inhibit iuswl& secrti~~. Conversely, a 
role for micr0fiWuent.s was s from the ef- 
fects of cytoch&& B of insulin s&r&ion (51, 
although doubts have beeu expr@ssed about the 
specifkity of this agent. 
tion of calcium-evoked insulin secretion. This sug- 
gests an important role for F-actin in the insulin 
secretion mechanism. 
2. EXPERIMENTAL 
2.1. Media 
Islet isolation and static secretion experiments 
using intact islets were carried out in a bicarbonate 
buffered medium (pH 7.4) [8] equilibrated with 
02/co2 (19: 1, v/v). 
PhaDoidin is a F 5pecific drug 
which ma&s s%aichionWri~My vritfh mu& F-actin 
in vitro Ed). It st&biiizes p&ln#rixed a&n against 
depolyuke&Miou, pEcrtonlyt3c &$asMn and heat 
denaturatiou without infltMaddnilk “its physiological 
functions V] aMi h$nce shifts the +M&ru bet- 
wean glcrbylar and’fdami8ntous actin in favour of 
The pulsation medium used for high ‘voltage 
discharge [9] and perifusion of the permeabilized 
islets, had the following composition (mM): Na+, 
72; K+, 70; Mg’+, 1; Cl-, 72; isethionate, 70; 
EGTA, 1; ATP, 1; Hepes [4-(2-hydroxyethyl)-l- 
piperazine-ethanesulphonic a id], 16; glucose, 5; 
and bovine serum albumin (RSA) (0.5 mg/ml). 
CaCl2 was added to give final concentrations of 
10T6 M or 10s8 M Ca2’ and the pH was adjusted 
to 7.0 with NaOH. 
We report hate that in B C&J of Sslets of 
Laugerhaus which have been parm@Mized by 
hi& voltage electric d&charge, phalloidin 
peuetrates readily and induces iguificant stimula- 
2.2. Isolation of islets 
* To whom correspondence should be addressed 
Islets were isolated from the pancreata of male 
Wistar rats (100-150 g) by a collagenase digestion 
technique [lo]. After isolation the islets were prein- 
cubated for 30 min at 37°C in the bicarbonate buf- 
fered medium containing 5 mM glucose. 
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2.3. Static incubations 
After the preincubation period the islets were . 
washed several times in the bicarbonated buffered 
medium. Groups of 3 islets were incubated at 37°C 
in the medium supplemented with 0.5 mg/ml BSA 
and 5 mM or 20 mM glucose, with and without ad- 
dition of phalloidin at concentrations ranging 
from lo-’ M to lo-’ M. 
2.4. Perifusion 
After the preincubation period the islets were 
washed several times in the pulsation medium con- 
taining lo-* M Ca2+. Then groups of 50 islets were 
transferred to pulsation cells containing 1 ml of 
the medium and subjected to 3 discharges of 
3.6 kV cm-’ for 18~s (at 15 s intervais) and 
resuspended between discharges [9]. The islets 
were then placed on a 10 pm-mesh filter (Plastok, 
Birkenhead) in a Swinnex filter holder (Mfllipore) 
and perifused using a Gilson peristaltic pump 
(Anachem, Luton). The islets were washed with 
pulsation medium at 37°C at a flow rate of 
1 ml/min with pulsation medium containing 
10T6 M or 10m8 M Ca2’ with and without addition 
of 10T4 M phalloidin for a further 10 min. Con- 
centrations of Ca2’ were controlled by EGTA buf- 
fers [ 1 l] and calculated using a modification of the 
ligand metal-binding programme of [ 121. 
Insulin concentrations in media were determined 
by radioimmunoassay, using guinea pig anti- 
insulin serum (donated by Dr W. Montague, 
University of Leicester), purified rat insulin stan- 
dards (Novo, Denmark) and ‘251-labelled bovine 
insulin iodinated in our laboratory by a 
chloramine-T method [13]. The antibody bound 
fraction was separated from the unbound fraction 
by precipitation in 12% polyethylene glycol 6ooo 
1141. 
2.5. Histology 
Some of the intact islets and some of the islets 
subjected to the high voltage exposure were in- 
cubated with trypan blue for 5 min [15] or 
rhodaminylphalloin (fig.1) for 30 min and then 
washed well before examination under a Leitz 
dialux 200 microscope. 
3. RESULTS AND DISCUSSION 
Concentrations of nhalloidin ranging from 
394 
Fig. 1. Shocked (a) and non-shocked (b) islets incubated 
with rhodaminylphalloin. Magnification = 140 X . 
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lo-’ M to lo-* M did not affect insulin secretion 
in static incubations of intact islets in the presence 
of 5.5 or 20 mM glucose (not shown). Islet cells 
were therefore rendered accessible to normally im- 
permeable molecules by exposure to a high voltage 
discharge [9]. A trypan blue test confirmed the 
- 
Fig.2. Insulin secretion from permeabilized islets 
perifused with phalloidin. (a) (m) Islets discharged and 
perifused in lo-* M Ca” (control channel) and (0) 
islets discharged and perifused in 10m8 M Ca*’ 
supplemented with 10V4 M phalloidin. (b) (m) Islets 
discharged and perifused in lO-‘j M Ca2’ (control 
channel) and (0) islets discharged and perifused in 
lo-* M Ca2’ supplemented with 10m4 M phalloidin. 
Points on the curve represent mean and the bars the 
SEM of 7 perifusions. Integrated areas under the curve 
were compared with the control and p was ~0.005 in 
each case, calculated by Student’s t-test. 
cells had been made permeable. Using the fluores- 
cent rhodaminylphalloin it was shown that B cells 
of intact islets are normally impermeable to 
rhodaminylphalloin and that the high voltage 
discharge allowed entry of this molecule (fig.1). 
Insulin secretion from B cells in the permeabiliz- 
ed islets was stimulated in perifusian medium con- 
taining 10S6 M Ca2’ (fig.2) in comparison to 
lo-’ M Ca”. Addition of 10e4 M phalloidin to the 
perifusion medium significantly increased insulin 
secretion at both concentrations of calcium over a 
lo-min period (fig.2 and table 1). 
These results clearly show that entry of 
phalloidin into B cells is essential for its action and 
an increase in microfilament polymerization by 
this apparently specific drug will increase insulin 
secretion in permeabilized islets but not in intact 
islets. Possible ways in which F-actin, along with 
tubulin and myosin, might work together to 
facilitate the intracellular movement of insulin 
storage granules. prior to their secretion have 
recently been discussed [161. 
Table 1 
Effect of phalloidin perifusing permeabilized islets 
Calcium Integrated insulin secretion over n P 
concentration a IO-min period 
of medium (M) (pg/islet per min) 
Control With 10m4 M 
(mean f SE) phalloidin 
(mean f SE) 
10-E 18.35 f 0.75 23.50 f 0.87 7 <0.005 
10-6 26.34 zt 1.78 43.93 f 3.92 7 c 0.005 
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